Article ID Journal Published Year Pages File Type
2910342 Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2010 4 Pages PDF
Abstract
We conclude that surfonylureas treatment leads to increased insulin and leptin levels in overweight type 2 diabetes men, metformin, or rosiglitazone treatment can reduce insulin and leptin levels, respectively, and effect of metformin on plasma leptin and insulin levels is more significant than that of rosiglitazone.
Related Topics
Health Sciences Medicine and Dentistry Cardiology and Cardiovascular Medicine
Authors
, , ,